Literature DB >> 27763996

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Michelle M Van Handel1, Charles E Rose, Elaine J Hallisey, Jessica L Kolling, Jon E Zibbell, Brian Lewis, Michele K Bohm, Christopher M Jones, Barry E Flanagan, Azfar-E-Alam Siddiqi, Kashif Iqbal, Andrew L Dent, Jonathan H Mermin, Eugene McCray, John W Ward, John T Brooks.   

Abstract

OBJECTIVE: A recent HIV outbreak in a rural network of persons who inject drugs (PWID) underscored the intersection of the expanding epidemics of opioid abuse, unsterile injection drug use (IDU), and associated increases in hepatitis C virus (HCV) infections. We sought to identify US communities potentially vulnerable to rapid spread of HIV, if introduced, and new or continuing high rates of HCV infections among PWID.
DESIGN: We conducted a multistep analysis to identify indicator variables highly associated with IDU. We then used these indicator values to calculate vulnerability scores for each county to identify which were most vulnerable.
METHODS: We used confirmed cases of acute HCV infection reported to the National Notifiable Disease Surveillance System, 2012-2013, as a proxy outcome for IDU, and 15 county-level indicators available nationally in Poisson regression models to identify indicators associated with higher county acute HCV infection rates. Using these indicators, we calculated composite index scores to rank each county's vulnerability.
RESULTS: A parsimonious set of 6 indicators were associated with acute HCV infection rates (proxy for IDU): drug-overdose deaths, prescription opioid sales, per capita income, white, non-Hispanic race/ethnicity, unemployment, and buprenorphine prescribing potential by waiver. Based on these indicators, we identified 220 counties in 26 states within the 95th percentile of most vulnerable.
CONCLUSIONS: Our analysis highlights US counties potentially vulnerable to HIV and HCV infections among PWID in the context of the national opioid epidemic. State and local health departments will need to further explore vulnerability and target interventions to prevent transmission.

Entities:  

Mesh:

Year:  2016        PMID: 27763996      PMCID: PMC5479631          DOI: 10.1097/QAI.0000000000001098

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

1.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

2.  Drug poisoning deaths in the United States, 1980-2008.

Authors:  Margaret Warner; Li Hui Chen; Diane M Makuc; Robert N Anderson; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2011-12

3.  Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.

Authors:  Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2013-02-12       Impact factor: 4.492

4.  Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.

Authors:  A Neaigus; M Miller; S R Friedman; D L Hagen; S J Sifaneck; G Ildefonso; D C des Jarlais
Journal:  Addiction       Date:  2001-06       Impact factor: 6.526

5.  Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review.

Authors:  Shauna Onofrey; Jasneet Aneja; Gillian A Haney; Ellen H Nagami; Alfred DeMaria; Georg M Lauer; Kelsey Hills-Evans; Kerri Barton; Stephanie Kulaga; Melinda J Bowen; Noelle Cocoros; Barbara H McGovern; Daniel R Church; Arthur Y Kim
Journal:  Ann Intern Med       Date:  2015-08-18       Impact factor: 25.391

6.  Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-06       Impact factor: 17.586

7.  Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-05-16       Impact factor: 17.586

8.  Supply of buprenorphine waivered physicians: the influence of state policies.

Authors:  Bradley D Stein; Adam J Gordon; Andrew W Dick; Rachel M Burns; Rosalie Liccardo Pacula; Carrie M Farmer; Douglas L Leslie; Mark Sorbero
Journal:  J Subst Abuse Treat       Date:  2014-08-02

9.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  165 in total

1.  HIV Care Initiation Delay Among Rural Residents in the Southeastern United States, 1996 to 2012.

Authors:  Brettania L W Lopes; Joseph J Eron; Michael J Mugavero; William C Miller; Sonia Napravnik
Journal:  J Acquir Immune Defic Syndr       Date:  2017-10-01       Impact factor: 3.731

2.  Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)-Estimating HCV incidence in an urban emergency department population.

Authors:  Y-H Hsieh; A V Patel; G S Loevinsohn; D L Thomas; R E Rothman
Journal:  J Viral Hepat       Date:  2018-07-03       Impact factor: 3.728

3.  The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids.

Authors:  Pedro Mateu-Gelabert; Honoria Guarino
Journal:  Int J Drug Policy       Date:  2018-04-05

Review 4.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Authors:  Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

5.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

6.  A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Authors:  Constance A Benson; Judith S Currier; Carlos Del Rio; Joel E Gallant; Roy M Gulick; Jeanne M Marrazzo; Douglas D Richman; Michael S Saag; Robert T Schooley; Paul A Volberding
Journal:  Top Antivir Med       Date:  2017 Dec/Jan

7.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

8.  State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.

Authors:  Marcelo H Fernández-Viña; Nadya E Prood; Adam Herpolsheimer; Joshua Waimberg; Scott Burris
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

9.  The Impact of Policy Changes on Heroin and Nonmedical Prescription Opioid Use among an Incarcerated Population in Kentucky, 2008-2016.

Authors:  Amanda M Bunting; Grant Victor; Erika Pike; Michele Staton
Journal:  Crim Justice Policy Rev       Date:  2019-03-31

10.  Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.

Authors:  Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Yih-Ing Hser; Gregory M Lucas; Amy C Justice; Janet P Tate
Journal:  Drug Alcohol Depend       Date:  2019-09-04       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.